Cedar Mountain Advisors, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Cedar Mountain Advisors, LLC
- $503 Million
- Q3 2025
A detailed history of Cedar Mountain Advisors, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Cedar Mountain Advisors, LLC holds 38 shares of ARWR stock, worth $1,461. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38Holding current value
$1,461% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARWR
# of Institutions
324Shares Held
99.5MCall Options Held
444KPut Options Held
568K-
Black Rock Inc. New York, NY15.7MShares$603 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.5MShares$597 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY10.6MShares$408 Million3.05% of portfolio
-
State Street Corp Boston, MA6.37MShares$245 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$201 Million1.65% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $4.07B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...